MEDICAMEQ — Medicamen Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Medicamen Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	16.6	38.2	208	148	37.6
Net Total Accounts Receivable
Net Total Receivables	791	848	887	789	720
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	960	1,230	1,634	1,596	1,645
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	894	921	918	910	861
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,940	2,257	2,785	2,946	2,969
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	533	727	826	846	782
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	611	792	851	876	841
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	1,329	1,465	1,934	2,070	2,128
Total Liabilities & Shareholders' Equity	1,940	2,257	2,785	2,946	2,969
Total Common Shares Outstanding